CVS Health stock fell 43% in 2024, facing uncertainty and potential restructuring in 2025.

From Nasdaq: 2025-01-09 07:45:00

CVS Health (NYSE: CVS) has been struggling, with shares plummeting by 43% in 2024. Despite diversification, investors have seen losses, with the stock losing more than half its value over the past three years. Management changes have been made, including a new CEO, and potential business restructuring. Uncertainty surrounds CVS’s future earnings, with low margins and missed expectations. The company may undergo significant changes in 2025 to improve operations. Investors are advised to wait and observe before considering investing due to the high level of risk and unclear outlook for the healthcare stock.



Read more at Nasdaq: After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?